Starting today, a new rule requires drug commercials to clearly show the potential side effects and when not to take the medicine. This update to a 2007 law gives the FDA more control over drug advertising. Drugmakers have six months to comply with the new rule fully, and it’s unclear how aggressively the FDA will enforce the requirements, per Ropes & Gray. It’s a good step, but a lot more is needed.

Biotechnology firms have emerged as a beacon of hope in the medical field, heralding innovative treatments and personalized medicine. However, as these companies grow, there’s a concerning trend: biotech firms increasingly adopt practices typical of Big Pharma. While this might seem like a natural progression, it carries significant downsides that could undermine the principles that make biotech companies unique.

Pharma companies have increasingly turned to websites as crucial tools for disseminating information, engaging healthcare professionals (HCPs) and patients, and driving brand loyalty. However, simply having a website is not enough; its effectiveness must be measured to ensure it meets its objectives and provides a meaningful return on investment. Here are key metrics and methods for evaluating the efficacy of pharmaceutical product websites.

The media loves to stir the flames of division with articles on everything from politics to healthcare. However, the truth about healthcare and pharma is often hard to digest for many of us. We would rather blame everyone for our healthcare problems but also need to look inward. Here are some inconvenient truths.

Undoubtedly, medications alleviate symptoms, manage chronic conditions, and save lives. However, a concerning trend has emerged—the overselling of prescriptions as the panacea for all health woes. When people believe they can lower their A1C by taking a pill instead of emphasizing diet and exercise, it creates a bigger problem for all of us.